NeuroBo Pharmaceuticals Inc (NRBO)

Finanzdaten der NeuroBo Pharmaceuticals Inc-Aktie (NRBO)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.162	-	-	-	-
Operating Expenses	4.055	-	-	-	-
Benefits Costs and Expenses	3.98	-	-	-	-
Costs And Expenses	2.29% 3.893	3.806	2.52	10.43	3.104
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	2.29% -3.893	-3.806	-2.52	-10.43	-3.104
Net Interest Income/Expense	0.162	-	-	-	-
Interest Income/Expense After Provision For Losses	0.162	-	-	-	-
Income/Loss From Continuing Operations Before Tax	420.16% -3.818	-0.734	-2.604	-4.676	-3.113
Income Tax Expense/Benefit	-	-	-	26.33	-
Income/Loss From Continuing Operations After Tax	420.16% -3.818	-0.734	-2.604	-31.01	-3.113
Net Income/Loss	420.16% -3.818	-0.734	-2.604	-4.676	-3.113
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.33% 40.61	40.47	40.47	1.6849	0.8887
Diluted Average Shares	0.33% 40.61	40.47	40.47	1.6849	0.8887
Basic Earnings Per Share	350.00% -0.09	-0.02	-0.06	5.02	-3.50
Diluted Earnings Per Share	350.00% -0.09	-0.02	-0.06	5.02	-3.50
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-